Continuous Glucose Monitors to Regulate Glucose Levels in Type 2 Diabetics - (Protocol 3) (CGM_IRB-3)

Savvysherpa

Status

Completed

Conditions

Type2 Diabetes

Treatments

Device: Activity Tracker

Behavioral: Coaching

Device: Continuous Glucose Monitor (CGM)

Study type

Interventional

Funder types

Industry

Identifiers

NCT03290768

Pro00022589

Details and patient eligibility

About

This study allows Type 2 diabetics to receive feedback from a continuous glucose monitor (CGM) as part of an educational program designed to help them better manage their glucose levels. Subjects will also wear an activity tracker to monitor their activity and observe its effect on their glucose levels. The educational program will involve calls from coaches to check subjects' progress and answer questions.

Enrollment

358 patients

Sex

All

Ages

65+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

Be diagnosed with type 2 diabetes
Be able to read and understand English
Have access to a telephone
Have a Medicare Advantage health plan through Senior Dimensions

Exclusion criteria

Pregnant
Blind
Deaf
Receiving chemotherapy or radiation to treat cancer (now or in past 6 months)
Misusing any drugs (including alcohol, painkillers, hallucinogens, or others)
Critically ill
Diagnosed with or experiencing:
- Kidney disease stages 4 and 5
- End stage renal disease
- Severe liver disease
- Dementia
- Schizophrenia
- Bipolar disorder
- Autism
- An intellectual or learning disability
- Arrhythmias other than atrial fibrillation
- Congestive heart failure
Has had a:
- Myocardial infarction within the last 6 months
- Stroke within the last 6 months
- Stroke that resulted in significant disability (e.g., unable to write clearly or walk)